A New Approach in Laser Surgery Using the Regenerative Solution in Children Diagnosed With Vascular Pathology

• Status: Completed
• Trial end date: 2021-10-27
• Target enrollment: 0
• Participant gender: All

Summary

Laser treatment (LT) is the first-line treatment for Vascular Pathology. However even when LT is based on the selective photothermolysis it causes the first-degree burns. While being typically benign by affecting only the epidermis, or outer layer of skin, the burn site is remaining red, dry, and very painful. As Haemoblock contains nanoparticles of silver and is known for both bactericidal and bacteriostatic effects, it likely decreases the potential for infection postoperatively. Furthermore, after fibrin replaces the superficial structure "Hemoblock-albumin", the polyacrylate matrix is plasmolyzed which initiates the cascade of signals required for the tissue regeneration processes. Objective of the study was to examine the effect of the Regenerative Solution "Hemoblock" in lowering postoperative complications in children diagnosed with Vascular Pathology undergoing a laser surgery if delivered with transdermal patches.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Center for Vascular Pathology, Moscow

Criteria

Inclusion Criteria:

• clinically diagnosed Vascular Pathology

Exclusion Criteria:

• age

• severe allergic reaction